首页> 外国专利> New regulatory sequences from the fascin gene, useful for providing dendritic cell-specific expression of e.g. antigens, e.g. for vaccination against tumors and infections

New regulatory sequences from the fascin gene, useful for providing dendritic cell-specific expression of e.g. antigens, e.g. for vaccination against tumors and infections

机译:来自fascin基因的新调控序列,可用于提供树突状细胞特异性表达,例如。抗原,例如用于预防肿瘤和感染的疫苗

摘要

Regulatory sequences (A) that provide specific expression in dendritic cells (DC). (A) are; (i) sequences from nucleotides (nt) n to 3069 of a 16951 base pairs (bp) sequence (S72), where n = 1, 1136, 1451, 1621, 1830, 2127, 2410 or 2700; (ii) sequences in clone DSM 13274 produced by amplification with primers (S37) and (m), where m = 36, 38-44; (iii) sequences containing at least a functional part of (i) or (ii), able to provide DC-specific expression; and (iv) sequences that hybridize to (i)-(iii) and provide DC-specific expression. All numbered sequences are reproduced. Independent claims are also included for the following: (1) recombinant nucleic acid (I) containing (A); (2) vector (II) containing (A) or (I); (3) preparing (M) genetically modified host cells (III) by transformation with (II); (4) (III) modified with (A), (I) or (II), or prepared by (M); (5) nucleic acid (A') of at least 15 nt that hybridizes specifically, under stringent conditions, with one strand of (A); (6) antigen-specific stimulation (M1) of T cells in vitro; (7) preparation of pharmaceutical composition from the T cells of (f); (8) preparation of DC able to stimulate T cell; (9) preparation of a pharmaceutical composition containing the DC; and (10) pharmaceutical composition containing (I), (II) or (III), (8) or (9).
机译:在树突状细胞(DC)中提供特异性表达的调控序列(A)。 (A)是; (i)16951个碱基对(bp)序列(S72)的从核苷酸(nt)n到3069的序列,其中n = 1,1136,1451,1621,1830,2127,2410或2700; (ii)通过用引物(S37)和(m)扩增产生的克隆DSM 13274中的序列,其中m = 36、38-44; (iii)至少包含(i)或(ii)的功能部分的序列,能够提供DC特异性表达; (iv)与(i)-(iii)杂交并提供DC特异性表达的序列。复制所有编号的序列。还包括以下方面的独立权利要求:(1)包含(A)的重组核酸(I); (2)含有(A)或(I)的载体(II); (3)通过用(II)转化制备(M)基因修饰的宿主细胞(III); (4)(III)经(A),(I)或(II)修饰或由(M)制备的; (5)在严格条件下与(A)的一条链特异性杂交的至少15nt的核酸(A'); (6)体外T细胞的抗原特异性刺激(M1); (7)从(f)的T细胞制备药物组合物; (8)制备能够刺激T细胞的DC; (9)制备含有DC的药物组合物; (10)药物组合物,其含有(I),(II)或(III),(8)或(9)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号